|
Thursday
March 28, 2002
• Tm Universal Array Launched by Strategic Partner Luminex
•
Lynx MPSS™ Data Introduced in Version 3.5 of the Celera Discovery
System™; Invites
You to Participate in Year End 2001 Conference Call
•
3-DP
Announces Webcast of Presentation At Banc of America Conference
Wednesday
March 27, 2002
•
Xerion
achieves two milestones in target validation collaboration with Byk
Gulden
• Nonlinear
Dynamics Appoints Tomy Digital Biology Company Ltd. as Its
Distributor in Japan
• Instream Partners Initiates Coverage on Ciphergen
With a Buy
Tuesday
March 26, 2002
• CAFC Confirms Biacore US Patent Position
•
Aspira
Biosystems Names New VP of Business Development
• InforMax
Licenses the GenoMax Enterprise Informatics System to the Johns
Hopkins University
• Human
Genome Sciences' Chairman and CEO to Present Keynote Address At World
Genomics Symposium and Exposition
Monday
March 25, 2002
• BioInsights Reports Protein Biochip Sales Are Poised for
Huge Growth (Get
Report)
• Bruker
AXS Announces Appointment of New CFO
• Signature BioScience Receives Its Third U.S. Patent for
MCS Technology (See
US Patent 6,338,968: Method and apparatus for detecting molecular binding
events)
• Nobex
Announces Collaboration With Pharmacia For Oral Delivery of Protein
Drug
• Astex
Announces Structure-Based Drug Discovery Collaboration with Aventis Pharmaceuticals;
Receives
Milestone Payment from AstraZeneca for Human Cytochrome P450 Program
• New
FAST™ PAK Protein Array Kit Improves Stability and Signal Strength
Compatible with DNA microarray robots and scanners
Friday
March 22, 2002
• LSBC Forms Alliance with ApoImmune
•
Proteomics Puts its Stamp on Pittcon; Analytical Chemists Say, 'Huh?'
-GenomeWeb
Thursday
March 21, 2002
• AxCell Biosciences Appoints Marius Sudol to Its Scientific
Advisory Board
•
GPC Biotech Reports 2001 as the Most Successful Year In Its Corporate
History ; shares
fall as Cell Genesys ends partnership
•
OGS
Preliminary Audited Results For the Year Ended 31 December 2001 ;
Update
on Vevesca (OGT 918)
Wednesday
March 20, 2002
• Compugen and Millennium Enter Collaboration for the
Prediction of Protein Pathways
• Xantos
Biomedicine AG is to receive 803,000 Euro to develop technology for
analysing gene functions
• FEATURE:
Microfluidics Under the Microscope -GenomeWeb
Tuesday
March 19, 2002
•
GPC
Biotech Announces Issuance of U.S. Patent for Technology to Identify
Disease-Specific Validated Targets
•
AxCell Appoints New Member to Scientific Advisory Board
• Caliper Adds Protein Separation Analysis to AMS 90 SE System
; Expands
Assay Menu for LabChip® High Throughput Screening System
• Sense
Proteomic Announces First Commercial Array of Functional Ion Channel
Proteins
Monday
March 18, 2002
• deCODE Announces Completion of MediChem Acquisition
•
Thermo
Electron CEO Highlights the Successes of the Company's "One Thermo"
Strategy at Pittcon 2002
• Thermo Finnigan Introduces Several New Products in the GC
and GC/MS Family
•
Cytogen
Receives Regulatory Approval In Canada for ProstaScint(R) Prostate Cancer
Imaging Agent
• Biology
Superstars to Align in Seattle March 24-26: Institute for Systems Biology
Hosts Grand Opening and First Annual Symposium
• Proteome
Systems and Cystic Fibrosis Foundation Therapeutics Inc. Announce
Strategic Alliance on Proteomics of Cystic Fibrosis
• Bruker
Daltonics Announces Six Novel Life-Science Products and Three New
Bioinformatics Software Releases at PittCon 2002
• SPR-MS
Collaboration Achieves Significant Milestones: Biacore and Bruker
Daltonics Announce First Results From Joint Studies
• Micronics and Honeywell Enter Microfluidic Technologies
Co-Promotion Agreement
Friday
March 15, 2002
• Applied Biosystems/MDS Sciex Win Patent Suit Against
Micromass
•
Myriad
says study shows cancer gene test utility
• Molecular
Mining Corp Expert Speaks at IIR 7th Annual Drug Discovery Meeting
Near San Diego
• Cohesive
Technologies' TurboFlow™ Chromatography That Eliminates Method
Development In Drug Discovery
•
Myriad
Publishes Results of 10,000 Genetic Tests For Risk of Breast, Ovarian
Cancer
•
Neurolab moves
in Europe on multiple biomarkers analysis through preclinical and clinical
trials
Thursday
March 14, 2002
• OGS and BioInvent form Therapeutic Antibodies Alliance
•
MediChem
Announces Stockholder Approval of Merger With deCODE
• MDS Announces Cash Dividend
• LION and GeneProt Team Up for Better Proteomics Integration
• BioITWorld
2002 News Summary through March 14
•
Accelrys
and Sun Microsystems Extend Alliance to Optimize Discovery Studio™
To J2EE™ Technology Standard
• Boston Biomedica Awarded NIH Grant For Commercial Development
of Pressure Cycling Technology (PCT) System For Genomics and Proteomics
• Nonlinear
Dynamics and Amersham Biosciences Collaborate to Automate Protein
Picking From Bands in 1-D Electrophoresis Gels
• PerkinElmer to Showcase New Technology At PittCon 2002
•
Compaq
chief's comment stuns biotech crowd
Wednesday
March 13, 2002
•
SEQUENOM and CuraGen to Apply Genetics and Proteomics To Validate
Novel Drug Targets
•
Proteome Systems to Enter Agricultural Diagnostics Market with C-Qentec
• InforMax
Invites You to Join Its Conference Call
• Anadys
Announces Annotation of The Riboproteome
•
Luminex
May Pick New CFO Next Week-GenomeWeb
Tuesday
March 12, 2002
• NextGen
Sciences: Prototype Protein Biochip Development for Protein Expression
Profiling and Novel Antibody Selection (pdf file)
• PerkinElmer
Life Sciences and NextGen Sciences Announce Corporate Partnership
to Launch the ProteinArray Workstation
• MindBranch:
Proteomics Research And Technologies Forecasted To Grow At Significant
Rates Through 2006
•
Amersham
Announces Agreement to Purchase Pharmacia's Shares In Amersham Biosciences
• Myriad and Abbott Form Drug Discovery Collaboration
• AnVil Announces New Name, Expanded Presence at BioITWorld
in Boston
• BioITWorld
2002 Exhibitor Profiles
• GeneFormatics
Announces the Availability of Human Oocyte Library for Drug Discovery
Collaboration
• AVAKI
Announces Three Customers to Accelerate Drug Discovery Using Comprehensive
Grid Software Product
• Illumina Gets $1.2M From NCI to Build Protein Immunoassay
Platform -GenomeWeb
Monday
March 11, 2002
•
AxCell
Finalizes Research Collaboration With Mount Sinai School Of Medicine
•
GeneData Announces Functional Genomics Collaboration In Anti-Infectives
Research
•
Medical
College of Wisconsin Invests $1 Million in Compaq Supercomputing
• Bruker
Daltonics to Host Analyst Booth Tour at Pittcon 2002
• Illumina
Receives $1.2 Million Phase 2 Grant From National Cancer Institute to
Develop Microarrays for Protein Profiling
• Amersham Biosciences, University of Washington In Proteomics
Collaboration
• Affinium Pharmaceuticals Appoints New CSO
• IDC Launches Company-Wide Initiative Focused on IT Opportunities
in Life Sciences
• CRS
Robotics Corporation to be Acquired by Thermo Electron
• Life
Sciences Professionals to Experience Advanced Storage Network Appliance
Technology at BioITWorld
• DoubleTwist Crashes and Burns; Assets Are Put on the Block
-GenomeWeb
Friday
March 8, 2002
•
MDS
Proteomics CEO to Discuss How Proteomics is Revolutionizing Drug Discovery
•
Ciphergen Adopts Stockholder Rights Plan
•
Genomics
Conferences to Feature Proteomics, Target Identification & Validation
Advances on March 11-14 in Princeton, NJ
• Bio-Rad
Changes Stock Symbol
•
U
at Buffalo Selects InforMax as a Key Partner to Create Center of
Excellence in Bioinformatics
Thursday
March 7, 2002
• Incellico Licenses CELL Ontological Database Platform to
Beyond Genomics: Informatics agreement to link gene response, protein
activity and metabolite dynamics
•
OGS
CEO to Step Down by Year-End
• Bruker AXS Reports Financial Results For the Year and the
4Q 2001
•
Genetronics
to Announce Clinical Study Results at Major Cancer Conference
• MDS
Reports Solid Start For 2002
Wednesday
March 6, 2002
• AxCell Enters Into Strategic Alliance With Thomas Jefferson
U. to Study Protein Implicated in Cancer
•
Lynx
Sells Amidate Oligonucleotide Patent Estate to Geron
• Scimagix
President and CEO to Speak at Silicon Valley Biotechnology Event
• Amersham
Biosciences Expands Capabilities in Affinity Chromatography: Agreements
Signed With Dyax Corp. and Affibody AB
Tuesday
March 5, 2002
• Ciphergen and Beckman Coulter Announce Alliance to
Automate Clinical Proteomics
• PerkinElmer
Life Sciences Introduces New Product Portfolio for Protein and Nucleic
Acid Detection
• OGS Appoints New President of Global Therapeutics
• U
at Buffalo Selects InforMax as a Key Partner to Create Center
of Excellence in Bioinformatics
•
Sangamo
Granted U.K. Patent Covering Design and Synthesis of Zinc Finger DNA-Binding
Proteins
• BioITworld
Conference & Expo to Highlight New Technologies and Their Impact On Life
Sciences
• LumiCyte
Moving Forward with Clinical Trials Of Protein Biomarker Profiles For
The Early Detection of Cancer
Monday
March 4, 2002
•
GeneProt and Zymark Reach Automation Technology Agreement for
U.S. and Europe
• LumiCyte
Moving Forward with Clinical Trials Of Protein Biomarker Profiles For
The Early Detection of Cancer
•
BD
Biosciences Discovery Labware and Kensey Nash Corporation Announce
An Agreement to Commercialize Product Line of Three-Dimensional Cell Culture
Scaffolds
•
Discovery
Partners CEO to Present Keynote Address at ScreenTech 2002
Friday
March 1, 2002
• MDS Proteomics Develops Litmus Test for Drug Efficacy
• Bruker
Daltonics Comments on its Stock Price
•
3-DP
Appoints New VP And General Counsel
• Metaphorics, Syrrx Ink Ligand-Docking Partnership-GenomeWeb
•
The
promise of proteins: Proteomics is biotech's new buzzword -SeattleTimes.com
Thursday
February 28, 2002
•
ProteoTech
Selected to Give Presentation at Seattle's Invest Northwest Conference
on March 4, 2002
•
Syrrx Announces Issuance of Patent and Appointment of CSO
• Fujitsu Licenses LabBook's Technology to Integrate
Life Science Information
Wednesday
February 27, 2002
• Proteomics Ramps Up to Deliver More Insights, Better Drug
Targets
•
Genomics
Conferences to Feature Proteomics, Target Identification & Validation
Advances on March 11-14 in Princeton, NJ
• ActivX
Appoints New Executive VP, Business Development
• Caprion Enters into Proteomics Agreement with McGill
University
• Structural Bioinformatics Announces Novel Method to Predict
HIV-1 Drug Resistance
•
OGS-Marconi
JV Debuts Its Protein Atlas. But Customers Will Have to Wait Til June-GenomeWeb
Tuesday
February 26, 2002
•
Integrative Proteomics Changes Name to Affinium Pharmaceuticals
•
Affinium
forms Subsidiary, Ylektra, for Selective Transformation Chemistry
for Lead Optimization
• Compugen Expands Proteomics Product Line
•
Zyomyx
and Specialty Laboratories Collaborate to Discover Novel Patterns Of Disease
Markers
•
Triad
Therapeutics Publishes Novel Method for Use of NMR in Structure-Based
Drug Design
• Apple, United Devices Join Roster for BioITWorld
Conference & Expo
•
Merrimack
Pharmaceuticals Secures Patent to Recombinant Human Alpha Fetoprotein
•
Open
Channel Software Releases Unique Gene Expression BioInformatics Tools
•
Proteome
Systems and Cryosite announce agreement for storage of valuable
biological samples for proteomic research
• An 'Atlas' to Count the Genes -Wired.com
Monday
February 25, 2002
• Unveiling of the First-Ever Protein Atlas of the Human Genome
•
Prolinx' CTO Joins Elite to Define Human Proteome Project
• Anadys
Announces SBIR Grant Award in Riboproteomics
•
3-DP
Promotes New COO and Member to Board of Directors
• Molecular
Mining Presents at the Genome Tri-Conference
Friday
February 22, 2002
• Beyond Genomics Forms Strategic Technology Partnership with
Micromass
•
MediChem
Reports 2001 Financial Results
Thursday
February 21, 2002
• Bruker
Daltonics Reports Revenue of $92.7 M, and Income Before Taxes of $6.0
M for FY 2001
•
Myriad shares falls 10% after sell call
• AxCell Appoints New Member to Scientific Advisory Board
•
deCODE
and MediChem Receive Early Hart-Scott-Rodino Clearance
•
SignalGene
and Arqule to Apply Compound Design Technology to p38 Map Kinase
Drug Discovery Program
• Start-Up Protein Chip Firm Protometrix Names First
President -GenomeWeb
•
Protein
Microarrays May Just Be the Next Big (Little) Thing -GenomeWeb
• ProteoTech Receives Issuance of Two U.S. Patents Pertaining
to Therapeutics And Animal Models for Alzheimer's Disease
Wednesday
February 20, 2002
• 3
- DP, Astex, Caprion, Cytogen, GPC Biotech,
Hybrigenics, Scimagix, Structural Bioinformatics,
and Structural GenomiX Presenting at BIO CEO & Investor Conference
2002
•
Anadys
Pharmaceuticals and Structural GenomiX Announce Strategic Collaboration
for Drug Discovery
• Accelrys Announces the Release of First Applications Optimized
for IBM Servers
•
ProteoTech
Receives $2.78 Million in NIH Research Funding to Study the Cause, Prevention
and Treatment of Brain Amyloid Protein Deposits Associated With Alzheimer's
Disease
• Astex Appoints Director of Biophysics
• CombiMatrix Corporation Receives Grant from National Institutes
of Health for Continued Development of Its Protein Biochip Technology
•
Gene
Mappers May Have Missed Half The Genes -Forbes.com
Tuesday
February 19, 2002
• Beyond Genomics and diaDexus Enter Research and License
Agreement to Identify and Develop Cancer Biomarkers and Drug Targets
•
Ciphergen
Enters China Market
• Cytogen to Present at the BIO CEO & Investor Conference
•
Luminex
Updates Status of Bioinformatics Unit
• Disease
Sciences Announces Sensitive Detection of Prion Protein in About 1
mL of Human Urine
Monday
February 18, 2002
• NeuroLab
Establishes Proteomics Collaborations with Two Undisclosed Pharmaceutical
Companies
• NextGen Sciences Launches New Website Detailing the Protein
Biochip Consortium
Friday
February 15, 2002
•
J. of Clinical Oncology Article Demonstrates Link Between Loss of
MDA-7 Protein and Tumor Invasiveness
• PerkinElmer
Appoints New VP of Life Sciences Research & Development, CSO
Thursday
February 14, 2002
•
Ciphergen
Reports Record Financial Results for the Q4 And Fiscal Year 2001 ;
Ciphergen Signs CRADA With the NIAID for AIDS Research;
Ciphergen
and Aaron Diamond AIDS Research Center Announce Drug Discovery
Research Collaboration
• Genomic
Solutions Reports Financial Results for Q4 and Fiscal Year 2001
•
Stryker
Receives Canadian Approval for OP-1
• Celera
Protease Inhibitor Enters Development for Chagas' Disease
•
Eli
Lilly, Indiana U., Purdue Create Proteomics R&D Consortium-GenomeWeb
•
Compugen
Uncovers Prostate-Specific Proteins -GenomeWeb
Wednesday
February 13, 2002
• Beyond Genomics Closes $11 Million Financing Round
•
Syrrx Achieves First Research Milestone in Cubist Collaboration
• Incyte Reports 2001 Q4 and Year End Financial Results
• Compugen Reports Q4 and Year End 2001 Financial Results
• Compugen Discovers Novel Prostate-Specific Proteins Encoded
by the PSA Gene
•
ProdiGene
Launches First Large Scale-Up Manufacturing of Recombinant Protein From
Plant System
• Thermo Electron Reports Fourth Quarter Results
Tuesday
February 12, 2002
• Eprogen's ProteoSep™: Shows Promise in the 'Fingerprinting'
of Bacterial Pathogens
•
Cytogen Reports Q4 and Full Year Results for 2001
• 454
Corporation Names New President and CEO
•
Myriad
Participate in Workshop at NCState University's 2002 Emerging Issues
Forum on Biotechnology
• InforMax Announces Alliance With Sun Microsystems
in Asia Pacific
• Applied
Biosystems and Vanderbilt Form Proteomics Collaboration
• geneticXchange K1 Data Integration Middleware Platform Provides
Solid Foundation for Genomics Collaborative's New Tantalus Database
•
DPI
Reports Q4 and Year End 2001 Financial Results
Monday
February 11, 2002
•
Ciphergen
Confirms Use of Its ProteinChip® System in Ovarian Cancer Study Published
in The Lancet
•
Genomic Solutions and Proteometrics Announce Exclusive License
Agreement
•
Caliper
Appoints Susan Evans, Ph.D. Vice President of Product Development
• Gryphon
and Avecia Enter Strategic Alliance to Make Gryphon's Chemically
Synthesized Protein Therapeutics
Friday
February 8, 2002
•
Ciphergen Conference Call and Webcast
• Genomic Solutions Q4 Earnings and Conference Call Notification
• Correlogic, Ciphergen Tools Help Develop Cancer Diagnostic
-GenomeWeb
Thursday
February 7, 2002
• GeneProt Licences OGS' Automated Proteomics Patents
•
OGS
Opens New Office in New Jersey
•
Apple
Releases Apple/Genentech BLAST, Significantly Accelerating Protein
And DNA Searches
• Incyte Appoints New Executive VP and Chief Drug Discovery
Scientist
• IBM
Life Sciences Puts Drug Discovery On The Fast Track At The Silicon
Valley World Internet Center
• Bio-Rad Announces Record Financial Results for 2001
• Thermo Electron to Hold Conference Call on Thursday, February
14, 2002
•
Vertex
Reports Year End 2001 Financial Results
Wednesday
February 6, 2002
• Breakthroughs
in Effort to Map Body's Proteins -Boston.com
• Cytogen to Announce Q4 Results and Host Conference Call
•
InforMax Announces Q4 Results
•
Caliper
Reports Increased Revenue, Contracted R&D in Q4 -GenomeWeb
•
G-Protein
Coupled Receptors (GPCRs) Drug Discovery Conference To Take Place In Philadelphia,
PA, March 18-19, 2002
Tuesday
February 5, 2002
•
MDS Proteomics Acquires Top Quality cDNA Collection
•
Lynx to Provide Immunology Research Services for Keryx Biopharmaceuticals
•
Bio-Rad
Shareholders Approve Increase in Number of Authorized Shares
• Sangamo Reports Q4 2001 and Year-End Financial Results
• BIO CEO & Investor Conference 2002 Spotlights Industry Leaders
• PerkinElmer
to Present At 2002 Merrill Lynch Conference Detailing Position
in the Functional Genomics and Proteomics
Monday
February 4, 2002
•
Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal
2002
•
De
Novo Pharmaceuticals Announces a Major Initiative to Develop a Comprehensive
Platform for Chemoinformatics with SUN Microsystems
• Incyte
announced today its intention to release fourth quarter fiscal year 2001
earnings results
Friday
February 1, 2002
•
Genomics
Conferences to Feature Proteomics, Target Identification & Validation
Advances on March 11-14 in Princeton, NJ
•
Cambridge Antibody Technology Reports Outcome of Annual General Meeting
•
Discovery
Partners International Presents at UBS Warburg Global Healthcare Services
Conference
• Bruker
AXS Announces Technology Joint Venture for Innovative X-ray Optics
• BioProcessors
Raises $6 Million in Series A Financing
Thursday
January 31, 2002
•
Hybrigenics
and Mindsense Biosystems Announce Collaboration In the Field of
Mental Disorders
•
Ciphergen
Develops Enhanced ProteinChip Arrays for Drug Discovery Applications
•
Luminex
Beats Fourth Quarter Consensus Net Loss Estimate While Annual Revenues
Increase 143%
•
Bio-Rad
to Report Year-End Financial Results on February 7, 2002
• CuraGen Reports Fourth Quarter and Year End 2001 Financial
Results And 2002 Projected Milestones and Financial Guidance
• UC Berkeley Extension Delivers "Bleeding Edge"
Bioinformatics
• UK
Medical Research Council and Celera Sign Agreement on Access to
Genomic Database
Wednesday
January 30, 2002
• LSBC Reports Financial Results for 2001
•
Kinexus
Bioinformatics Announces the Launch of its Fourth Proteomics Analysis
Service
• Bayer
and CuraGen Advance Four Projects And Select Additional Obesity
and Diabetes Targets
• Biovation Opens US Office
• ABI, PE, Millipore Create Automated Protein-Identification
Troika -GenomeWeb
•
Announcing
IBC's The Impact of Post-Translational and Chemical Modifications
on Protein Therapeutics May 8-10, 2002
• The
Market For Protein-Protein Interactions: Technologies With Tremendous
Growth Potential
• Consensus Achieves First Milestone in its Collaboration
with Vertex
Tuesday
January 29, 2002
• BD Biosciences Enters Into Collaboration With the Harvard
Institute of Proteomics to Determine Human Gene Function
•
Signature Acquires Protein Design Labs' Small Molecule Group
• Sangamo Announces Q4 2001 Teleconference
Monday
January 28, 2002
• Syrrx Appoints New VP of Technology
•
Gryphon Sciences Completes $26 Million Financing for Rapid Expansion
• Scimagix to Support Regulatory Standards for Electronic
Pharmaceutical Data
• U.S.
Court Grants Favorable Orders to MorphoSys in CAT Patent Disputes
• RLX
Technologies and Platform Partner to Offer Platform Clusterware
On RLX Systems for Bioinformatics Industry
• Protein Solutions, Inc. Expands U.S. Sales Force
• Albany Molecular Research, Inc. Announces Agreement with
Myriad
•
AstraZeneca
Implements Global License of Accelrys Modeling Software
• Xerion
and ProCorde Enter Cardiovascular Collaboration (pdf file)
Friday
January 25, 2002
• Making
Proteomics More Efficient: Alliance Between Roche and Bruker
Daltonics to Develop Highly Sensitive Protein Analysis
•
Institute
for Systems Biology Completes Move to Custom, 64,000-Square-Foot Facility
• HUPO President Says 2002 Will Be the Year of the Proteome
-GenomeWeb
Thursday
January 24, 2002
•
Eprogen
Offers Considerable Benefits in Drug Discovery With the Introduction of
ProteoSep™
•
Structural GenomiX and RoboDesign International Announce Completion
and Successful Operation of Automated Crystallization Imaging Technology
•
CuraGen
to Discuss Year End 2001 Financial Results Via Conference Call on January
31, 2002
• TissueInformatics Secures $12.5 Million in Financing, Moves
Forward With Toxicity Screening and Drug Target Discovery Tools
• Syrrx Forms Multi-Year Research Collaboration with Pharmacia
Corporation
Wednesday
January 23, 2002
•
Mascot Proteomics Software Ported to IBM's AIX Operating System
• MDS
Proteomics Strengthens International Team
• Astex
Announces Plans for New, Purpose-Built Facility on Cambridge Science Park
• Galapagos
Genomics and Exelixis Collaborate in Gene Function Analysis
•
Accelrys
Announces Three-Year Agreement With Compaq To Accelerate Materials
Research
• Visualization
Expertise From AnVil Informatics Prominently Featured in New Book
•
3-DP
Announces Webcast of Presentation At U.S. Bancorp Piper Jaffray Healthcare
Conference
• X-MINE
Launches Opus for Biological Knowledge Discovery
• Genome
Institute of Singapore selects the geneticXchange K1 Data Integration
Middleware Platform
• Applied
Biosystems Reports Second Quarter Fiscal 2002 Earnings Per Share of
24 Cents Excluding In-process R&D Charge
• Top
Supplier in Mass Spectrometry Market is Applied Biosystems
Tuesday
January 22, 2002
• Craig Venter resigns as head of Celera
•
Venter
Steps Down From Celera -Forbes.com
•
Venter
quits as president of Celera -Boston.com
• Medarex
and ZYCOS Establish Alliance to Develop CANVAS™ Targets into
Human Antibody Therapeutics
• DoubleTwist Announces New Customers, Realigned Management
Team
•
Cytogen
Announces $8 Million Private Placement
•
BioSilico
2002: The Strategic Summit on In Silico Biology
Monday
January 21, 2002
• Protein Bioinformatics Market Expected to Reach Nearly $500
million in 2006
•
Molecular Mining Corporation Announces the Release of GeneLinker Gold
Version 2.0
•
Imperative
Players in Biotechnology, IT and Life Science Announced Participation
in BioITWorld Conference & Expo Hong Kong 2002
Friday
January 18, 2002
• NCSC Named U.S. Mirror Site for the ExPASy Proteomics
Server
•
Luminex
Q4 Financial Results to be Released Jan. 31, 2002
• 3-DP Names New Member to Board of Directors
Thursday
January 17, 2002
• ACLARA Announces eTag™ Proteomics Collaboration With
Stanford Researchers
• Prolinx
Announces Release of Two New Products for the Proteomics Market
•
IBC
Announces New Emerging Microarray Technologies Event
• Protedyne Introduces The BioCube System
• Applera
Corporation Declares Dividend
Wednesday
January 16, 2002
• Amersham Ranked Top Supplier in Proteomics Market
•
Proteomics
Conference & Exposition to Take Place in Princeton, NJ, March 13-14, 2002
• Compugen and diaDexus Announce Agreement for Identification
of New Diagnostic Markers and Therapeutic Targets
• AnVil Informatics Names New CTO
• MitoKor Establishes Agreements to Study the Human Mitochondrial
Proteome
•
NextGen
and Cytomyx to Develop Protein Biochips for Cancer -GenomeWeb
Tuesday
January 15, 2002
• LSBC to Release Q4 Earnings and Host Conference Call
• Applied
Biosystems and Celera Q2 FY 2002 Financial Results Scheduled
for Release January 23, 2002
•
Thermo
Finnigan Introduces ProteomeX™, the First Completely Integrated
Multidimensional Proteomics Workstation ; Thermo
Finnigan Introduces the Surveyor® MSQ™, the Smallest, Fastest,
And Most Sensitive Quadrupole MS Detector
•
New
U.S. composition patent firmly solidifies Stressgen's position
in heat shock protein fusion technology (See
Patent 6,338,952: Stress proteins and uses therefor)
•
Vertex
Announces the Date of Its Q4 and Year End 2001 Financial Results Conference
Call and Webcast
• Bioinformatics,
L.L.C. study: The Tools & Techniques of Protein Science: Catalyzing
the Future of Proteomics
• Book Review: Introduction to Protein Structure by Branden
and Tooze
Monday
January 14, 2002
• ProteEx Announces Positive Results in Breast Cancer Initiative
•
Biolog
Reports Completion of Microarrays Measuring 2,000 Cell Phenotypes At Biotech
Conference
• Lab-on-a-Chip Technology Is Poised for Rapid Growth, Reveals
Technical Insights
•
Incyte
Appoints New Members to Board of Directors
•
Founding
Chairman of Proteomics Firm Syn X Dead -GenomeWeb
Friday
January 11, 2002
• 3-Dimensional Pharmaceuticals Appoints VP To Oversee Development
Programs
• QIAGEN Opens North American Headquarters in Montgomery County,
Maryland
Thursday
January 10, 2002
• Is This The Next Big Biotech Bang? -Forbes.com
•
Celera Announces Achievement of Research Milestone in Aventis
Collaboration
•
GPC
Biotech Achieves Milestone in Osteoarthritis Alliance With Aventis
Pharma
•
Lynx
Files Patents for Atherosclerosis and Breast Cancer Gene Targets
• Genomic Solutions and PerkinElmer Sign Amended Distribution
Agreement
• With $1B in the Bank, Invitrogen Hungry for Proteomics,
Informatics Acquisitions -GenomeWeb
Wednesday
January 9, 2002
• 3-D Models Give Proteins Shape -Wired.com
•
Cellzome
Publishes Novel Approach for the Systematic Use of Protein Interaction
Maps in Drug Discovery in Nature
•
Tripos Targets Continued Strong Growth in 2002 Following a Record
Year For 2001
•
Oxford
GlycoSciences, Medarex and Genmab Announce Comprehensive
Campaign To Treat Breast Cancer
• MDS Proteomics Opens New Pathway to Faster Drug Development
• Bruker
AXS Announces Exercise of Underwriters' Common Stock Over-Allotment
Option
• Caprion has New CFO and Executive VP, Legal Affairs
Tuesday
January 8, 2002
• Applied
Biosystems Announces Commercial Launch of Next Generation Proteomics
Analysis System
• Signature
to Acquire PrimeCyte to Rapidly Advance its Drug Discovery Platform
• X-MINE
Launches X-Miner On-Line -- XOL -- for Microarray Data Mining and Biological
Knowledge Discovery
• World
Genomics Symposium and Exposition Offers the Only Show Uniquely Focused
on Genomics
• Gene Logic and Compugen Partner to Expand Genomic
Content Offering
• New
protein analyzer speeds gene research -company
• Caliper Announces Multiple Sales of LabChip High Throughput
Screening Systems
•
Triad
Therapeutics Announces Issuance of Patent Related to the Use of NMR
For Protein Structure Analysis
• 3-Dimensional Pharmaceuticals Licenses TPO Peptide from
GlaxoSmithKline
•
Vertex
Provides Corporate Update and Outlook for 2002
• Caprion to Present at JP Morgan H&Q Healthcare Conference
•
Lynx
to Present at JP Morgan H&Q Healthcare Conference
Monday
January 7, 2002
• Applied Biosystems to Hold New Product Webcast and Conference
Call
• Gyros
AB and ACE BioSciences Reveal Proteomics Collaboration and
Begin Field Tests of Prototype
• IBM
and Accelrys Form Global Strategic Alliance to Transform Drug R
and D
• GeneFormatics
Expands Management with the Addition of Chief Business Officer
• IDG Launches Bio-IT World: First Publication Targeting
the Intersection of Information Technology and Life Sciences to Debut
in March
• PerkinElmer
Extends Agreement With Nonlinear Dynamics to Deliver Automated
1-D Gel Protein Picking
• Caliper's Presentation at the JPMorgan H&Q Conference to
Be Webcast
•
Structural
GenomiX Announces Drug Discovery Partnership With Millennium;
Structural
GenomiX to Collaborate with Aventis on Lead Compound Identification
• AxCell Expands Management And Announces Formation Of Scientific
Advisory Board To Pursue Broader Range Of Research
• ActivX Appoints New VP And General Counsel
•
Phylos
Announces Strategic Acquisition and Formation of Phylos GmbH
Friday
January 4, 2002
• Amersham Biosciences Ranked Top Supplier in Proteomics Market
•
Waters Corporation Announces the Reorganization of Corporate Operating
Structure
•
Incyte
Presentation to Be Webcast by JPMorgan H&Q From Its 20th Annual Healthcare
Conference
• 3-Dimensional Pharmaceuticals Announces DiscoverWorks®
Drug Discovery Alliance With Johnson & Johnson Pharmaceutical Research
& Development
Thursday
January 3, 2002
• Lynx Enters AIDS Research Collaboration With Dana-Farber
Cancer Institute
•
Hybrigenics
to Present at the 2002 JP Morgan H&Q Healthcare Conference in San Francisco
• Bruker
Daltonics Reports Strong Q4 Life-Science Systems Bookings, Provides
Guidance for 2002
• Caliper Names Wood to Head Corporate Communications and
Investor Relations
•
Tripos
Announces Partnership With Pfizer in Multi-Million Dollar Discovery
Software Agreement
• Genomatica to Develop 'Next-Generation' In Silico Technology
Under DOE Grants
•
Pharma
& Biotech M & A Climate to be Assessed at Partnering Conference January
28-30, 2002 in San Diego
• Applied Biosystems and Celera Diagnostics to Webcast
Investor Meeting
•
Protein
Pathways Bails on Bioinformatics Business Model, Chases Drug-Discovery
Gold -GenomeWeb
Wednesday
January 2, 2002
• Rib-X Pharmaceuticals Secures $22 Million in Series A Financing
• New
European Biotech Report From MRG, Inc. Forecasts the Growth of Bio Chip
Sector to 2010
• 3-Dimensional Pharmaceuticals Announces Webcast Of Presentation
at JP Morgan H&Q Healthcare Conference
• Norak
Biosciences and Universal Imaging Collaborate on Optimization
Of Secondary Screening for GPCRs
|
